Acta Neurol Belg (2017) 117:777–778 DOI 10.1007/s13760-016-0735-x LETTE R T O T HE EDI T OR Could pregabalin cause oculomotor symptoms in lower dose? A case with down beat nystagmus as a side effect 1 1 2 1 • • • Aysen Suzen Ekinci Seyma Ciftci Berfu Cavus Ibrahim Aydogdu Received: 11 November 2016 / Accepted: 7 December 2016 / Published online: 17 December 2016 Belgian Neurological Society 2016 Dear Editor, drug levels before symptoms appeared. However, Carba- mazepine and lamotrigine serum concentrations were in Dizziness and ataxia are two known adverse effects of therapeutic range (carbamazepine: 9 lg/ml; normal-range pregabalin use. Oculomotor symptoms may also be seen in 8–12 lg/ml, lamotrigine: 10 lg/ml; normal-range: pregabalin intoxication although it is reported rarely. Pre- 2–15 lg/ml) during the symptomatic period. There were no gabalin can cause these symptoms by reducing excitatory triggering head positions for her symptoms. Neurologic neurotransmitter secretion in the nervous system and by examination was performed during the time when she decreasing excitatory inputs in the brainstem. Here, we are complained of dizziness and down beat nystagmus was reporting a case in which the individual has oculomotor detected without any restrictions of eye movements in all symptoms
Acta Neurologica Belgica – Springer Journals
Published: Dec 17, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera